Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes

Area of Science:

• Neuropharmacology
• Dopaminergic system research

Background:

• (-)-3-PPP is a dopaminergic agent with mixed agonist/antagonist properties.
• Understanding its long-term effects is crucial for dopaminergic system modulation.

Purpose of the Study:

• To investigate the behavioral and biochemical effects of sub-chronic (-)-3-PPP treatment.
• To assess the impact of repeated (-)-3-PPP administration on dopamine system responsivity.

Main Methods:

• Sub-chronic administration of (-)-3-PPP (8 mg/kg, s.c., b.i.d. for 21 days) in rats.
• Behavioral assessments of locomotor activity.
• In vivo biochemical analysis of central dopamine synthesis.
• Acute challenge doses of (-)-3-PPP to evaluate drug sensitivity.

Main Results:

• No changes in basal locomotor activity or dopamine synthesis after 24-hour withdrawal.
• Pretreated rats showed reduced sensitivity to acute low-dose (-)-3-PPP challenge (0.125 and 1.0 mg/kg).
• No change in sensitivity to a high-dose (8.0 mg/kg) acute challenge.
• Plasma levels of (-)-3-PPP remained unchanged by pretreatment.

Conclusions:

• Sub-chronic (-)-3-PPP treatment induces modest down-regulation of dopamine autoreceptors.
• Evidence suggests up-regulation of postsynaptic dopamine receptors.
• These adaptations modulate the overall dopaminergic system response to the drug.